.png%3Fv%3D63861899706&w=96&q=100){kind=small}
The Australian: AdAlta, SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapy
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask AdAlta a question about this update.